Spots Global Cancer Trial Database for uveal
Every month we try and update this database with for uveal cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. | NCT06022029 | Triple Negative... Diffuse Large B... Follicular Lymp... Lymphoma, Non-H... Mantle Cell Lym... Bladder Cancer Uveal Melanoma,... Cervix Cancer Carcinoma in Si... Head and Neck S... Skin Cancer Metastatic Canc... Tumor, Solid Tumor Recurrenc... | ONM-501 Cemiplimab | 18 Years - | OncoNano Medicine, Inc. | |
| IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma | NCT04109456 | Metastatic Mela... | IN10018 Cobimetinib Atezolizumab | 18 Years - | InxMed (Shanghai) Co., Ltd. | |
| A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. | NCT06022029 | Triple Negative... Diffuse Large B... Follicular Lymp... Lymphoma, Non-H... Mantle Cell Lym... Bladder Cancer Uveal Melanoma,... Cervix Cancer Carcinoma in Si... Head and Neck S... Skin Cancer Metastatic Canc... Tumor, Solid Tumor Recurrenc... | ONM-501 Cemiplimab | 18 Years - | OncoNano Medicine, Inc. | |
| SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver | NCT01473004 | Stage IV Uveal ... | Sir-Spheres® | 18 Years - | Thomas Jefferson University | |
| Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma | NCT05308901 | Melanoma, Uveal | Pembrolizumab Lenvatinib | 18 Years - | Providence Health & Services | |
| Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma | NCT05308901 | Melanoma, Uveal | Pembrolizumab Lenvatinib | 18 Years - | Providence Health & Services | |
| Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma | NCT05308901 | Melanoma, Uveal | Pembrolizumab Lenvatinib | 18 Years - | Providence Health & Services | |
| Melphalan Chemoreduction for Ocular Melanoma | NCT05893654 | Uveal Melanoma | Melphalan Injec... Plaque brachyth... | 18 Years - | Hospital das Clínicas de Ribeirão Preto | |
| A Study to Assess PV-10 Chemoablation of Cancer of the Liver | NCT00986661 | Cancer Metastat... Hepatocellular ... Metastatic Mela... Metastatic Ocul... Metastatic Uvea... Metastatic Lung... Metastatic Colo... Metastatic Colo... Metastatic Brea... Metastatic Panc... | PV-10 (10% rose... | 18 Years - | Provectus Pharmaceuticals | |
| SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver | NCT01473004 | Stage IV Uveal ... | Sir-Spheres® | 18 Years - | Thomas Jefferson University | |
| A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. | NCT06022029 | Triple Negative... Diffuse Large B... Follicular Lymp... Lymphoma, Non-H... Mantle Cell Lym... Bladder Cancer Uveal Melanoma,... Cervix Cancer Carcinoma in Si... Head and Neck S... Skin Cancer Metastatic Canc... Tumor, Solid Tumor Recurrenc... | ONM-501 Cemiplimab | 18 Years - | OncoNano Medicine, Inc. | |
| SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver | NCT01473004 | Stage IV Uveal ... | Sir-Spheres® | 18 Years - | Thomas Jefferson University | |
| SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver | NCT01473004 | Stage IV Uveal ... | Sir-Spheres® | 18 Years - | Thomas Jefferson University | |
| A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma | NCT01551459 | Metastatic Uvea... | Dacarbazine Sunitinib | 18 Years - | The Clatterbridge Cancer Centre NHS Foundation Trust | |
| Treatment Of Radiation Retinopathy Trial | NCT00811200 | Uveal Melanoma | ranibizumab triamcinolone a... sham | 18 Years - | Leiden University Medical Center | |
| A Study to Assess PV-10 Chemoablation of Cancer of the Liver | NCT00986661 | Cancer Metastat... Hepatocellular ... Metastatic Mela... Metastatic Ocul... Metastatic Uvea... Metastatic Lung... Metastatic Colo... Metastatic Colo... Metastatic Brea... Metastatic Panc... | PV-10 (10% rose... | 18 Years - | Provectus Pharmaceuticals |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
